The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist.
about
Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic DiseasesVascular Remodelling and Mesenchymal Transition in Systemic SclerosisEndothelial-Mesenchymal Transition in Regenerative MedicineStimulation of Transforming Growth Factor-β1-Induced Endothelial-To-Mesenchymal Transition and Tissue Fibrosis by Endothelin-1 (ET-1): A Novel Profibrotic Effect of ET-1.Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages.Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study.Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of Systemic Sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?Increased expression of latent TGF-β-binding protein 4 affects the fibrotic process in scleroderma by TGF-β/SMAD signaling.Angiogenesis Dysregulation in the Pathogenesis of Systemic Sclerosis.Autophagy attenuates endothelial-to-mesenchymal transition by promoting Snail degradation in human cardiac microvascular endothelial cells.TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases.Endothelin-1 is associated with fibrosis in proliferative diabetic retinopathy membranes.Human Fibrotic Diseases: Current Challenges in Fibrosis Research.Endothelial to Mesenchymal Transition Represents a Key Link in the Interaction between Inflammation and Endothelial Dysfunction.A Potential Link Between Oxidative Stress and Endothelial-to-Mesenchymal Transition in Systemic Sclerosis
P2860
Q26748338-567056A9-9C00-4DAC-AC09-8325C7F377C1Q26749091-D15C3D89-5CEF-455B-8145-24658B2F5EA3Q26752901-7454E024-21B0-4617-B8F6-8803D60028EFQ36119874-8BD1FFF8-444F-415F-ACD7-A969BCA37722Q36192785-CCC6218A-A103-4C4D-9EF4-5D723E75A2BEQ37316247-8582C425-2BF5-47B9-93D4-C00F5E36F2DFQ38710580-2A5E9666-0B29-47B2-AA61-597CA8586163Q38927336-A6250D19-040E-4A06-B85D-01DDB1AF769AQ41169103-0A0BCE60-7801-4257-A4E4-12391CECBAE0Q41622328-54F6D1ED-DCFF-4FC7-8B36-961FB02C6A40Q44537770-FC40D4DA-E329-4CA5-A1D0-B70956FE5D67Q48206535-0D76C592-C2E5-4B24-AD8F-388C64B3D7E3Q52536468-5478F566-91CC-46CB-B4B0-1AC3070E775CQ54982965-7ECF784E-111C-4120-8A78-1434AC3423B6Q57072741-C3BE218F-2022-4E2A-8745-7D8F5B556E0C
P2860
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
The Endothelial-mesenchymal Tr ...... othelin-1 Receptor Antagonist.
@en
The Endothelial-mesenchymal Tr ...... othelin-1 Receptor Antagonist.
@nl
type
label
The Endothelial-mesenchymal Tr ...... othelin-1 Receptor Antagonist.
@en
The Endothelial-mesenchymal Tr ...... othelin-1 Receptor Antagonist.
@nl
prefLabel
The Endothelial-mesenchymal Tr ...... othelin-1 Receptor Antagonist.
@en
The Endothelial-mesenchymal Tr ...... othelin-1 Receptor Antagonist.
@nl
P2093
P50
P356
P1476
The Endothelial-mesenchymal Tr ...... othelin-1 Receptor Antagonist.
@en
P2093
Daria Capece
Edoardo Alesse
Francesco Carubbi
Gianluca Pecetti
Ilenia Pantano
Marc Iglarz
Piero Ruscitti
Stefano Turricchia
P304
P356
10.3899/JRHEUM.150088
P407
P50
P577
2015-08-15T00:00:00Z